NEW DELHI: Equity benchmarks Sensex and Nifty ended in the red on Friday, dragged down by losses in shares of bank, IT, auto and energy heavyweights.
In sync with most Asian peers, Indian market incurred losses as investors remained on the sidelines awaiting the outcome of Trump-Xi G20 meet on Saturday.
Experts said that the undercurrent of the market was bearish and may see a decisive movement after Union Budget.
"Global, as well as domestic factors, are weighing on market sentiment. G20 meet is on investors radar while back home, concerns over liquidity crunch in NBFC space and slow monsoon is adding to the nervousness," said Rajnath Yadav, Senior Research Analyst, Choice Broking.
Sensex ended 192 points, or 0.48 per cent, down at 39,394.64, with 19 stocks in the red and 11 in the green.
The NSE Nifty settled 53 points, or 0.45 per cent, lower at 11,788.85. Among the 50 stocks in the index, 18 advanced and 32 declined.
However, on a weekly basis, both Sensex and Nifty inched up by about half-a-per cent.
Let's take a look at the highlights of Friday's session:
Over 200 stocks hit lower circuits
As many as 201 stocks, including Cox & Kings, Eros International Media, 8K Miles Software Services, Onelife Capital Advisors and Keynote Financial Services hit lower circuits on BSE.
On the other hand, Manpasand Beverages, Reliance Communications, Arrow Greentech, Emami Realty and MBL Infrastructures were among the 138 stocks that hit upper circuits.
201 stocks hit 52-week lows
Alkem Laboratories, Castrol India, Glaxosmithkline Pharmaceuticals, Glenmark Pharmaceuticals, Gujarat Narmada Valley Fertilizers & Chemicals, Monsanto India and TVS Motor Company were among 201 stocks that hit their 52-week lows.
On the other hand, Bajaj Finserv, Bajaj Finance, Godrej Properties, Havells India, State Bank of India and Titan were among the 44 stocks that hit 52-week highs.
DHFL plunges 12%
Shares of Dewan Housing Finance Corporation (DHFL) closed 11.75 per cent down at Rs 72.10 after it deferred the release of its fourth-quarter results which were scheduled to be announced on June 29. DHFL will now announce the March quarter earnings on July 13. Meanwhile, media reports suggested lenders to the firm have started work on a restructuring plan.
Glenmark Pharma extends losses
Falling for the sixth session in a row, Glenmark Pharmaceuticals settled 1.24 per cent lower at Rs 442.80 even as the company said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood. The stock has come off over 14 per cent in the last six sessions.
DLF gains nearly 2%
SharRead More – Source
[contf]
[contfnew]
ET Markets
[contfnewc]
[contfnewc]
